United States Clinical Oncology Next Generation Sequencing Market Size
According to a research report published by Spherical Insights & Consulting, the US Clinical Oncology Next Generation Sequencing Market is anticipated to reach USD 988.79 Million by 2035, growing at a CAGR of 14.98% from 2025 to 2035. The market growth is attributed to the growing prevalence of cancer, the adaptability of next-generation sequencing, and growing investments by the US government in the healthcare and research sectors.